Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Tirzepatide Shows Promise in OSA and Oral Health Management, claims study Jacinthlyn Sylvia30 Jun 2025 9:00 PM ISTA recent study published in the Journal of the American Dental Association found that Tirzepatide presented a novel strategy for treating obstructive...
Tirzepatide Demonstrates Consistent Efficacy in OSA Across All Severity Levels, suggests research Jacinthlyn Sylvia30 May 2025 8:30 PM ISTA recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep apnea (OSA) symptoms and...
Tirzepatide Shows 50% More Weight Loss Than Semaglutide in First Head-to-Head Study Dr. Kamal Kant Kohli13 May 2025 9:15 AM ISTIn the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater weight loss compared to...
Switching to Tirzepatide better than Increasing Dulaglutide Dose in poorly controlled Type 2 Diabetes: Study Dr Riya Dave9 April 2025 9:00 AM ISTResearchers have found in a new research that among patients with poorly controlled type 2 diabetes, switching from dulaglutide to tirzepatide...
Medical Bulletin 03/ April/ 2025 Dr. Bhumika Maikhuri3 April 2025 3:00 PM ISTHere are the top health news for the day:Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human...
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure Dr. Bhumika Maikhuri3 April 2025 8:15 AM ISTThe drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...
Tirzepatide Leads to Significant Weight Loss and Better Heart & Kidney Health in Type 1 Diabetes: Study Finds Medha Baranwal29 March 2025 9:00 AM ISTUSA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 diabetes (T1D). Over 21 months,...
Anti-Obesity Drugs Tirzepatide and Semaglutide Offer Health Benefits but Cost found prohibitive: New Research Shows Medha Baranwal20 March 2025 9:30 AM ISTUSA: A recent economic evaluation has highlighted the significant long-term health benefits of tirzepatide and semaglutide in managing obesity among...
Tirzepatide Lowers albuminuria among Type 2 Diabetes Patients: Study Dr Riya Dave17 Feb 2025 9:00 PM ISTA post hoc analysis of trial data published in Diabetes Care found that adults with type 2 diabetes receiving tirzepatide experienced greater...
Neuro-ophthalmologists concerned over Ophthalmic complications in patients on antidiabetic GLP-1 medications: JAMA Dr. Kamal Kant Kohli14 Feb 2025 8:15 PM IST A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link...
Use of Semaglutide and tirzepatide use linked to ophthalmic complications, finds study Jacinthlyn Sylvia5 Feb 2025 9:00 PM ISTAlmost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in 2023. These medications,...
